Injection Molding Industry Update March 2019
Bridgepoint has examined and published the financial details of the Injection Molding Industry for the first quarter of 2019.
Public physician practices, surgery centers and hospitals are currently trading at a median multiple of 9.8x (TEV / LTM EBITDA), down from the most recent cycle peak of 11.0x reached in June 2015.
Industry valuations follow the S&P 500 index relatively closely. However, public market data is limited as most providers are private.
Midwest banks have traditionally traded at discounted valuations relative to the broader S&P Financials Sectors Index, but the confluence of the Wells Fargo scandal negatively impacting large banks and the Trump election signaling regulatory relief (more positively buoying smaller banks) have had the effect of eliminating that discount.